BC Platforms continues to develop its Asia strategy with the opening of a new subsidiary in Singapore. Singapore has a fast-growing market in precision medicine, and great interest in advancing genomics-related research and innovation, both of which can be boosted with BC Platforms’ technology. The location in Singapore provides a gateway to serving the Asian markets, and will support BC Platforms’ goal to build cohort studies representing Asia’s rich multi-ethnicity.
